POPULARITY
Categories
12 episodes with interventional
11 episodes with interventional
8 episodes with interventional
7 episodes with interventional
23 episodes with interventional
8 episodes with interventional
3 episodes with interventional
5 episodes with interventional
5 episodes with interventional
4 episodes with interventional
16 episodes with interventional
6 episodes with interventional
3 episodes with interventional
4 episodes with interventional
4 episodes with interventional
5 episodes with interventional
6 episodes with interventional
5 episodes with interventional
Diagnosing hypertension, known as a "silent killer," is incredibly important. Interventional cardiologists Ricardo Yaryura, MD, Jeffrey Rossi, MD and Daniel Molloy, MD, explain the diagnosis, traditional treatments and a newer option for uncontrolled blood pressure. You can also watch the video recording on our Vimeo channel here. For more health tips & news you can use from experts you trust, sign up for Sarasota Memorial's monthly digital newsletter, Healthe-Matters.
Below-the-knee (BTK) arterial disease remains one of the more challenging areas in vascular care, particularly in patients with chronic limb-threatening ischemia (CLTI), where heavy calcification complicates endovascular treatment. As new calcium-modifying technologies emerge, an important question remains: what evidence supports their use in BTK interventions? In this episode of BackTable Vascular & Interventional, host Dr. Sabeen Dhand speaks with vascular surgeon Dr. Paul Foley of Doylestown Health about the Disrupt BTK II clinical trial from Shockwave Medical, which evaluates the performance of peripheral intravascular lithotripsy (IVL) in heavily calcified BTK disease. --- This podcast is supported by: Shockwave Medicalhttps://shockwavemedical.com/ --- SYNPOSIS Dr. Foley begins by outlining his training and the evolution of his vascular surgery practice, setting the stage for a broader discussion on how BTK interventions have changed over the past decade. The conversation explores shifts in access strategies, procedural approaches, and the unique characteristics of calcification encountered in CLTI. Because BTK calcium differs from calcification seen elsewhere in the peripheral vasculature, imaging and device selection play a particularly important role when planning IVL-based therapies. Dr. Foley reviews the design and outcomes of the Disrupt BTK II trial, where devices such as the Shockwave M5+ and S4 catheters were used to modify calcified plaque, demonstrating encouraging safety and performance signals. The discussion then turns to emerging technologies, including Shockwave's Javelin catheter, designed to deliver focused pressure waves to fracture dense calcium within peripheral arteries. Dr. Foley describes how the device fits into BTK workflows, including technique considerations and its use alongside adjunctive therapies such as balloon angioplasty. The episode also addresses the ongoing skepticism surrounding IVL in BTK disease, emphasizing the need for careful patient selection, procedural precision, and continued multidisciplinary collaboration as the field works to refine treatment strategies and improve outcomes for patients with peripheral artery disease (PAD). --- TIMESTAMPS 00:00 - Introduction08:20 - Evolution of Below-the-Knee Treatments11:10 - Differences in BTK Calcification13:13 - Imaging and Technology in BTK Interventions15:18 - Disrupt BTK II Trial Data and Results23:17 - Introduction to the Javelin Device26:39 - Technique Considerations with Javelin28:36 - Comparing Javelin and E831:17 - Future Directions for Lithotripsy Technology35:30 - Skepticism Around IVL in BTK Disease38:47 - Final Thoughts --- RESOURCES Disrupt BTK II Trialhttps://www.jvascsurg.org/article/S0741-5214(24)02063-9/fulltext
If you're a physician with at least 5 years of experience looking for a flexible, non-clinical, part-time medical-legal consulting role… ...Dr. Armin Feldman's Medical Legal Coaching program will guarantee to add $100K in additional income within 12 months without doing any expert witness work. Any doctor in any specialty can do this work. And if you don't reach that number, he'll work with you for free until you do, guaranteed. How can he make such a bold claim? It's simple, he gets results… Dr. David exceeded his clinical income without sacrificing time in his full-time position. Dr. Anke retired from her practice while generating the same monthly consulting income. And Dr. Elliott added meaningful consulting work without lowering his clinical income or job satisfaction. So, if you're a physician with 5+ years of experience and you want to find out exactly how to add $100K in additional consulting income in just 12 months, go to arminfeldman.com. =============== Get the FREE GUIDE to 10 Nonclinical Careers at nonclinicalphysicians.com/freeguide. Get a list of 70 nontraditional jobs at nonclinicalphysicians.com/70jobs. =============== Interventional cardiologist Dr. Rishin Shah shares how he built a multi-service private practice in Texas and how the business side of medicine pushed him to create tools that make practices run better. After a decade in practice and eight years as an owner, he explains what made the biggest difference: delegating early, hiring for soft skills, and building systems that reduce the practice's dependence on the physician. He also breaks down how he uses AI and automation to reduce administrative work, improve patient experience, and protect physician time, then explains why those solutions became businesses of their own. Along the way, he shares examples of offshoring support roles, documenting SOPs with modern tools, automating patient intake and reactivation, and using specialty-specific workflows to keep teams aligned. You'll find links mentioned in the episode at nonclinicalphysicians.com/dynamic-private-practice/
"ASRA Answers: Premedication Before Interventional Spine Procedures in Patients with Iodinated Contrast Allergy—Is It Necessary?." From ASRA Pain Medicine News, February 2026. See the original article at www.asra.com/february26news for figures and references. This material is copyrighted. Support the show
Meralgia Paresthetica Education and the Pain Boards This podcast episode from the NRAP Academy features Dr. David Rosenblum discussing Meralgia Paresthetica, a mononeuropathy affecting the lateral femoral cutaneous nerve. The condition involves entrapment or compression of this purely sensory nerve as it passes under the inguinal ligament near the anterior superior iliac spine, causing burning pain, tingling, and numbness in the anterior lateral thigh. Key clinical points covered include the nerve's L2-3 origin from the lumbar plexus, common causes such as obesity, tight clothing, pregnancy, and diabetes, and the absence of motor weakness or reflex changes. Diagnosis is primarily clinical, though ultrasound can visualize nerve entrapment effectively. Treatment approaches range from conservative management including weight loss, avoiding tight clothing, physical therapy, and neuropathic pain medications (gabapentinoids, duloxetine, tricyclics) to interventional procedures. Dr. Rosenblu strongly advocates for ultrasound-guided nerve blocks over fluoroscopic or blind approaches, citing better visualization and reduced risk of nerve trauma. Advanced treatments mentioned include peripheral neuromodulation and cryoablation for refractory cases. The episode emphasizes that this condition is commonly tested on pain management board examinations (ABA, ABPM, FIPP, osteopathic boards) and can be significantly more painful and disabling than typically appreciated. Upcoming Courses and Training Opportunities: Ultrasound training available at nrappain.org Regenerative medicine training courses Comprehensive Question Bank for Pain Management board preparation covering ABA, ABPM, FIPP, and osteopathic examinations CME credits available through the platform Clinical consultation services available at Dr. Rosenblu's Brooklyn office for patients seeking treatment Meralgia Paresthetica Education and Clinical Guidance Overview: Focused on definition, anatomy, diagnosis, management, and board exam relevance for meralgia paresthetica. Anatomy and Pathophysiology: Nerve: lateral femoral cutaneous nerve (sensory only), typically arising from L2–L3. Course: traverses across the iliacus, passes under or through the inguinal ligament just medial to the ASIS, then enters the thigh. Sensory distribution: anterolateral thigh; anterior cutaneous division extends toward the knee. Etiology and Risk Factors: Common contributors: obesity, tight belts or clothing, pregnancy, prolonged sitting, diabetes, prior pelvic or hip surgery. Entrapment site: under the inguinal ligament near the ASIS (most frequent). Clinical Presentation: Symptoms: burning pain, tingling, numbness, dysesthesia localized to the anterolateral thigh. Provocation/relief: worse with standing or walking; relief with sitting or hip flexion. Neurologic exam: no motor weakness; no reflex changes. Diagnosis: Primarily clinical; Tinel's sign over the inguinal ligament may reproduce symptoms. EMG and nerve conduction studies are typically normal. Ultrasound: superficial nerve, generally easy to visualize, including in obese patients; can identify entrapment. Management Recommendations: First-line conservative care: weight loss; avoidance of tight belts/clothing; physical therapy; NSAIDs for inflammation. Pharmacologic options: gabapentin, pregabalin, duloxetine, tricyclic antidepressants; consider topical analgesic creams (e.g., lidocaine or anti-inflammatory combinations). Interventional approach: Ultrasound-guided nerve block is strongly recommended; the nerve lies lateral to the sartorius; real-time visualization enables precise, safe injection. Avoid fluoroscopic and blind approaches due to risk of further nerve trauma and post-procedure pain. Advanced interventions: Peripheral neuromodulation may provide benefit in select cases. Cryoablation has shown beneficial outcomes for the lateral femoral cutaneous nerve. Surgery is rarely required; options include neurolysis, decompression, or neurectomy as a last resort. Board Exam Preparation Emphasis: Key facts commonly tested: Involved nerve: lateral femoral cutaneous nerve. Nerve roots: L2–L3 (with population variants). Sensory-only nerve; absence of motor deficits. Compression site: under the inguinal ligament near the ASIS. First-line therapy: conservative measures; refractory cases: ultrasound-guided nerve block. Keywords to study: meralgia paresthetica; lateral femoral cutaneous nerve (also called lateral cutaneous nerve of the thigh). Practice Considerations: Severity: can be profoundly painful and disabling; often underappreciated. Referral: clinicians not trained in interventional techniques should refer patients to an interventionalist for diagnosis and treatment. Decisions and Recommendations Ultrasound guidance is the preferred modality for lateral femoral cutaneous nerve interventions, superseding fluoroscopic or blind approaches. Rationale: superior visualization, real-time feedback, and reduced risk of nerve trauma and post-procedural pain. Outreach and Resources NRAP Academy resources: Ultrasound training, regenerative medicine training, CME credits, and a comprehensive pain board question bank (ABA, ABPM, FIPP, osteopathic, and related exams). Clinical availability: Patient consultations for meralgia paresthetica offered in Brooklyn at www.AABPpain.com 718 436 7246 .
Meralgia Paresthetica Education and the Anesthesiology Boards This podcast episode from the NRAP Academy features Dr. David Rosenblum discussing Meralgia Paresthetica, a mononeuropathy affecting the lateral femoral cutaneous nerve. The condition involves entrapment or compression of this purely sensory nerve as it passes under the inguinal ligament near the anterior superior iliac spine, causing burning pain, tingling, and numbness in the anterior lateral thigh. Key clinical points covered include the nerve's L2-3 origin from the lumbar plexus, common causes such as obesity, tight clothing, pregnancy, and diabetes, and the absence of motor weakness or reflex changes. Diagnosis is primarily clinical, though ultrasound can visualize nerve entrapment effectively. Treatment approaches range from conservative management including weight loss, avoiding tight clothing, physical therapy, and neuropathic pain medications (gabapentinoids, duloxetine, tricyclics) to interventional procedures. Dr. Rosenblu strongly advocates for ultrasound-guided nerve blocks over fluoroscopic or blind approaches, citing better visualization and reduced risk of nerve trauma. Advanced treatments mentioned include peripheral neuromodulation and cryoablation for refractory cases. The episode emphasizes that this condition is commonly tested on pain management board examinations (ABA, ABPM, FIPP, osteopathic boards) and can be significantly more painful and disabling than typically appreciated. Upcoming Courses and Training Opportunities: Ultrasound training available at nrappain.org Regenerative medicine training courses Comprehensive Anestheisia and Question Bank for Pain Management board preparation covering ABA, ABPM, FIPP, and osteopathic examinations CME credits available through the platform Clinical consultation services available at Dr. Rosenblum's Brooklyn office for patients seeking treatment. Call 718 436 7246 or go to www.AABPpain.com Meralgia Paresthetica Education and Clinical Guidance Overview: Focused on definition, anatomy, diagnosis, management, and board exam relevance for meralgia paresthetica. Anatomy and Pathophysiology: Nerve: lateral femoral cutaneous nerve (sensory only), typically arising from L2–L3. Course: traverses across the iliacus, passes under or through the inguinal ligament just medial to the ASIS, then enters the thigh. Sensory distribution: anterolateral thigh; anterior cutaneous division extends toward the knee. Etiology and Risk Factors: Common contributors: obesity, tight belts or clothing, pregnancy, prolonged sitting, diabetes, prior pelvic or hip surgery. Entrapment site: under the inguinal ligament near the ASIS (most frequent). Clinical Presentation: Symptoms: burning pain, tingling, numbness, dysesthesia localized to the anterolateral thigh. Provocation/relief: worse with standing or walking; relief with sitting or hip flexion. Neurologic exam: no motor weakness; no reflex changes. Diagnosis: Primarily clinical; Tinel's sign over the inguinal ligament may reproduce symptoms. EMG and nerve conduction studies are typically normal. Ultrasound: superficial nerve, generally easy to visualize, including in obese patients; can identify entrapment. Management Recommendations: First-line conservative care: weight loss; avoidance of tight belts/clothing; physical therapy; NSAIDs for inflammation. Pharmacologic options: gabapentin, pregabalin, duloxetine, tricyclic antidepressants; consider topical analgesic creams (e.g., lidocaine or anti-inflammatory combinations). Interventional approach: Ultrasound-guided nerve block is strongly recommended; the nerve lies lateral to the sartorius; real-time visualization enables precise, safe injection. Avoid fluoroscopic and blind approaches due to risk of further nerve trauma and post-procedure pain. Advanced interventions: Peripheral neuromodulation may provide benefit in select cases. Cryoablation has shown beneficial outcomes for the lateral femoral cutaneous nerve. Surgery is rarely required; options include neurolysis, decompression, or neurectomy as a last resort. Board Exam Preparation Emphasis: Key facts commonly tested: Involved nerve: lateral femoral cutaneous nerve. Nerve roots: L2–L3 (with population variants). Sensory-only nerve; absence of motor deficits. Compression site: under the inguinal ligament near the ASIS. First-line therapy: conservative measures; refractory cases: ultrasound-guided nerve block. Keywords to study: meralgia paresthetica; lateral femoral cutaneous nerve (also called lateral cutaneous nerve of the thigh). Practice Considerations: Severity: can be profoundly painful and disabling; often underappreciated. Referral: clinicians not trained in interventional techniques should refer patients to an interventionalist for diagnosis and treatment. Decisions and Recommendations Ultrasound guidance is the preferred modality for lateral femoral cutaneous nerve interventions, superseding fluoroscopic or blind approaches. Rationale: superior visualization, real-time feedback, and reduced risk of nerve trauma and post-procedural pain. Outreach and Resources NRAP Academy resources: Ultrasound training, regenerative medicine training, CME credits, and a comprehensive pain board question bank (ABA, ABPM, FIPP, osteopathic, and related exams). Clinical availability: Patient consultations for meralgia paresthetica offered in Brooklyn at www.AABPpain.com 718 436 7246 .
Meralgia Paresthetica Education and the PM&R Boards This podcast episode from the NRAP Academy features Dr. David Rosenblum discussing Meralgia Paresthetica, a mononeuropathy affecting the lateral femoral cutaneous nerve. The condition involves entrapment or compression of this purely sensory nerve as it passes under the inguinal ligament near the anterior superior iliac spine, causing burning pain, tingling, and numbness in the anterior lateral thigh. Key clinical points covered include the nerve's L2-3 origin from the lumbar plexus, common causes such as obesity, tight clothing, pregnancy, and diabetes, and the absence of motor weakness or reflex changes. Diagnosis is primarily clinical, though ultrasound can visualize nerve entrapment effectively. Treatment approaches range from conservative management including weight loss, avoiding tight clothing, physical therapy, and neuropathic pain medications (gabapentinoids, duloxetine, tricyclics) to interventional procedures. Dr. Rosenblu strongly advocates for ultrasound-guided nerve blocks over fluoroscopic or blind approaches, citing better visualization and reduced risk of nerve trauma. Advanced treatments mentioned include peripheral neuromodulation and cryoablation for refractory cases. The episode emphasizes that this condition is commonly tested on pain management board examinations (ABA, ABPM, FIPP, osteopathic boards) and can be significantly more painful and disabling than typically appreciated. Upcoming Courses and Training Opportunities: Ultrasound training available at nrappain.org Regenerative medicine training courses Comprehensive PM&R Question Bank for Pain Management board preparation covering ABA, ABPM, FIPP, and osteopathic examinations CME credits available through the platform Clinical consultation services available at Dr. Rosenblum's Brooklyn office for patients seeking treatment Meralgia Paresthetica Education and Clinical Guidance Overview: Focused on definition, anatomy, diagnosis, management, and board exam relevance for meralgia paresthetica. Anatomy and Pathophysiology: Nerve: lateral femoral cutaneous nerve (sensory only), typically arising from L2–L3. Course: traverses across the iliacus, passes under or through the inguinal ligament just medial to the ASIS, then enters the thigh. Sensory distribution: anterolateral thigh; anterior cutaneous division extends toward the knee. Etiology and Risk Factors: Common contributors: obesity, tight belts or clothing, pregnancy, prolonged sitting, diabetes, prior pelvic or hip surgery. Entrapment site: under the inguinal ligament near the ASIS (most frequent). Clinical Presentation: Symptoms: burning pain, tingling, numbness, dysesthesia localized to the anterolateral thigh. Provocation/relief: worse with standing or walking; relief with sitting or hip flexion. Neurologic exam: no motor weakness; no reflex changes. Diagnosis: Primarily clinical; Tinel's sign over the inguinal ligament may reproduce symptoms. EMG and nerve conduction studies are typically normal. Ultrasound: superficial nerve, generally easy to visualize, including in obese patients; can identify entrapment. Management Recommendations: First-line conservative care: weight loss; avoidance of tight belts/clothing; physical therapy; NSAIDs for inflammation. Pharmacologic options: gabapentin, pregabalin, duloxetine, tricyclic antidepressants; consider topical analgesic creams (e.g., lidocaine or anti-inflammatory combinations). Interventional approach: Ultrasound-guided nerve block is strongly recommended; the nerve lies lateral to the sartorius; real-time visualization enables precise, safe injection. Avoid fluoroscopic and blind approaches due to risk of further nerve trauma and post-procedure pain. Advanced interventions: Peripheral neuromodulation may provide benefit in select cases. Cryoablation has shown beneficial outcomes for the lateral femoral cutaneous nerve. Surgery is rarely required; options include neurolysis, decompression, or neurectomy as a last resort. Board Exam Preparation Emphasis: Key facts commonly tested: Involved nerve: lateral femoral cutaneous nerve. Nerve roots: L2–L3 (with population variants). Sensory-only nerve; absence of motor deficits. Compression site: under the inguinal ligament near the ASIS. First-line therapy: conservative measures; refractory cases: ultrasound-guided nerve block. Keywords to study: meralgia paresthetica; lateral femoral cutaneous nerve (also called lateral cutaneous nerve of the thigh). Practice Considerations: Severity: can be profoundly painful and disabling; often underappreciated. Referral: clinicians not trained in interventional techniques should refer patients to an interventionalist for diagnosis and treatment. Decisions and Recommendations Ultrasound guidance is the preferred modality for lateral femoral cutaneous nerve interventions, superseding fluoroscopic or blind approaches. Rationale: superior visualization, real-time feedback, and reduced risk of nerve trauma and post-procedural pain. Outreach and Resources NRAP Academy resources: Ultrasound training, regenerative medicine training, CME credits, and a comprehensive pain board question bank (ABA, ABPM, FIPP, osteopathic, and related exams). Clinical availability: Patient consultations for meralgia paresthetica offered in Brooklyn at www.AABPpain.com 718 436 7246 .
William Sauvé, MD is CMO at Osmind and a leader in interventional psychiatry. A former Navy psychiatrist, he's expanded access to TMS and esketamine nationwide—helping build and scale hundreds of cutting-edge psychiatry clinics. In this episode, Drs. Tro, Brian, and William talk about… (00:00) Intro (05:47) Dr. Sauve's educational and professional experiences as a Navy psychiatrist during the Iraq War (15:26) The neurotransmitter theory of metabolic dysfunction and why it does not sufficiently explain depression (18:50) Common myths in medicine which are finally starting to be challenged (26:07) Why practicing psychiatry effectively takes courage and dedication (31:22) Trans-cranial Magnetic Stimulation as a treatment for depression (35:06) Cranial Electric Stimulation (37:18) Combining TMS with metabolic therapy for maximum impact (41:20) The possibility of complete, permanent remission of psychiatric disorders and the emergence of Interventional Psychiatry (51:36) Some practical, business-related reasons why TMS and Esketamine have not been widely adopted as treatments by psychiatrists For more information, please see the links below. Thank you for listening! Links: Please consider supporting us on Patreon: https://www.lowcarbmd.com/ Resources Mentioned in this Episode: Achilles in Vietnam (book): https://www.amazon.com/Achilles-Vietnam-Combat-Undoing-Character/dp/0684813211 William Sauvé, MD: Osmind: https://www.osmind.org/about/william-sauve-m-d Linkedin: https://www.linkedin.com/in/william-sauvé-md-45009813 Dr. Brian Lenzkes: Website: https://arizonametabolichealth.com/ Twitter: https://twitter.com/BrianLenzkes?ref_src=twsrc^google|twcamp^serp|twgr^author Dr. Tro Kalayjian: Website: https://www.doctortro.com/ Twitter: https://twitter.com/DoctorTro IG: https://www.instagram.com/doctortro/ Toward Health App Join a growing community of individuals who are improving their metabolic health; together. Get started at your own pace with a self-guided curriculum developed by Dr. Tro and his care team, community chat, weekly meetings, courses, challenges, message boards and more. Apple: https://apps.apple.com/us/app/doctor-tro/id1588693888 Google: https://play.google.com/store/apps/details?id=uk.co.disciplemedia.doctortro&hl=en_US&gl=US Learn more: https://doctortro.com/community/
In this episode, I'm joined by Dr. Christine Funke, glaucoma surgeon and lead author of the Interventional Glaucoma Consensus Treatment Protocol, for a timely and practice-shaping conversation on the future of glaucoma management.We explore how interventional approaches are redefining the standard of care—shifting treatment earlier, improving consistency in clinical decision-making, and driving better outcomes for patients. Whether you're a clinician navigating evolving glaucoma strategies or a patient seeking clarity and confidence in your care, this conversation offers meaningful insight into where glaucoma treatment is headed next.
Joshua Berman, MD, PhD, discusses how careful evaluation, patient priorities, and risk-benefit tradeoffs guide the use of interventional treatments when conventional approaches fall short. Dr. Berman also explains how tools such as ketamine, TMS, ECT, and neurofeedback can be used strategically—sometimes in sequence or combination—to address different vulnerabilities within mood-related brain circuits.Dr. Berman is Associate Professor of Psychiatry and Director of Interventional Psychiatry at NYU Langone Health.TopicsEvaluating patients who have not improved with medications or psychotherapyThe limitations of existing treatment guidelines for complex casesWhen and why sequencing or combining interventions may be appropriateEmerging approaches such as EEG-guided neurofeedback and focused ultrasoundBuilding a comprehensive, patient-centered interventional psychiatry programThis episode offers a clinician-level perspective on how interventional psychiatry is practiced today, and how new technologies may expand options for patients with the most challenging presentations.Chapters00:00 Introduction: Caring for Patients Who Don't Respond to Standard Treatment00:47 What Is Interventional Psychiatry?02:33 Evaluating Treatment-Resistant Presentations06:31 Precision, Patient Priorities, and Clinical Judgment09:35 Sequencing and Combining Interventions10:40 Limits of Treatment Guidelines12:18 The Future of Interventional Psychiatry13:23 Emerging Technologies: Neurofeedback and Focused Ultrasound17:15 Building a Comprehensive Interventional Program18:13 Tools vs. Understanding Brain CircuitsWatch Insights on Psychiatry on YouTubeExecutive Producer: Jon Earle
Interventional physiatrist Francisco M. Torres discusses his article, "A doctor's own prostate cancer recovery." He shares his vulnerable story of undergoing a robot-assisted radical prostatectomy and the unexpected shame and "erosion of dignity" caused by severe urinary incontinence. Francisco explains how his medical assumption that anatomical knowledge would ensure a fast recovery was wrong, and how pelvic floor physical therapy with biofeedback finally restored his function. The conversation advocates for a systemic shift toward "prehabilitation," arguing that men should start pelvic floor training weeks before surgery rather than being sent home with a pamphlet and diapers. Our presenting sponsor is Microsoft Dragon Copilot. Want to streamline your clinical documentation and take advantage of customizations that put you in control? What about the ability to surface information right at the point of care or automate tasks with just a click? Now, you can. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Offering an extensible AI workspace and a single, integrated platform, Dragon Copilot can help you unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise, and it's part of Microsoft Cloud for Healthcare, built on a foundation of trust. Ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended
This episode recorded live at Becker's 31st Annual The Business and Operations of ASCs features Dr. Nikhil Shetty, Chief Operating Officer, Midwest Interventional Spine Specialists. Dr. Shetty shares how independent ASCs are leveraging technology, lean operations, and price transparency to deliver faster, safer, and more patient-centered care while maintaining flexibility and efficiency in a growing outpatient surgery market.
This episode recorded live at Becker's 31st Annual The Business and Operations of ASCs features Dr. Nikhil Shetty, Chief Operating Officer, Midwest Interventional Spine Specialists. Dr. Shetty shares how independent ASCs are leveraging technology, lean operations, and price transparency to deliver faster, safer, and more patient-centered care while maintaining flexibility and efficiency in a growing outpatient surgery market.
This episode recorded live at Becker's 31st Annual The Business and Operations of ASCs features Dr. Nikhil Shetty, Chief Operating Officer, Midwest Interventional Spine Specialists. Dr. Shetty shares how independent ASCs are leveraging technology, lean operations, and price transparency to deliver faster, safer, and more patient-centered care while maintaining flexibility and efficiency in a growing outpatient surgery market.
In this episode of the Interventional Glaucoma Podcast, Prof. Gus Gazzard speaks with Dr. Marc Töteberg-Harms and Dr. Timothy Hamann about the health economics of interventional glaucoma. They discuss how MIGS can deliver long-term savings and quality-of-life benefits despite higher upfront costs, highlight evidence supporting its cost-effectiveness, and emphasize the growing ethical responsibility for clinicians to discuss MIGS options with eligible cataract patients. The ELIOS system (Bausch & Lomb) is manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17, Germany and by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany. ELIOS is CE marked for use in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). The ExTra II (laser class 4) has the brand name ELIOS. The ExTra II is equivalent to ExTra and AIDA devices. Find out more about ELIOS : http://bit.ly/4lWBJZ1
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Dr. Evgenij Potapov, a consultant senior surgeon and co-chairman of the mechanical circulatory support program in the Department of Thoracic and Cardiovascular Surgery at the German Heart Center in Berlin, about the guidelines on temporary mechanical circulatory support (tCMS) in adult cardiac surgery. Chapters 00:00 Intro 01:56 Segmentectomy vs Lobectomy News 18:51 JANS 1, CT Residents Emergency Surgery 20:56 JANS 2, Interventional vs Surgical 22:49 JANS 3, Robotic Vascular Surgery 24:32 JANS 4, Surgery vs Surveillance 26:30 Video 1, Branch-First Arch Replacement 28:19 Video 2, Manougian Technique Double Patch 30:14 Video 3, Bentall Surgery via RAM 31:23 Evgenij Potapov Interview 53:55 Upcoming Events They discussed the key elements of the guidelines, active unloading, and current trends and outcomes in tMCS. Additionally, they addressed protected cardiac surgery for high-risk patients, cardiac arrest, and the impact of recent changes to the donor heart allocation system on tMCS. Dr. Potapov also shared valuable insights on hints and tips for tMCS, anticoagulation management, and the future of tMCS. Furthermore, Joel elaborated on recent discussions regarding lobectomy vs segmentectomy in a detailed analysis. Joel also highlights recent JANS articles on a 10-year propensity-matched analysis on if we can safely train cardiothoracic surgical residents to perform emergency surgery, investigating the personality of interventional and surgical cardiovascular specialists, a clinical perspective on robotic-assisted vascular surgery, and a quality-of-life analysis of patients with moderately dilated aortic root or ascending aorta. In addition, Joel explores branch-first arch replacement, revisiting the Manougian technique with double-patch, and Bentall surgery via right anterior minithoracotomy. Before closing, Joel highlights upcoming events in CT surgery. JANS Items Mentioned 1.) Can We Safely Train Cardiothoracic Surgical Residents to Perform Emergency Surgery? A 10-Year Propensity-Matched Analysis 2.) Cut From the Same Cloth? Investigating the Personality of Interventional and Surgical Cardiovascular Specialists 3.) Robotic-Assisted Vascular Surgery: A Clinical Perspective 4.) Surgery Versus Surveillance: A Quality-of-Life Analysis of Patients With Moderately Dilated Aortic Root or Ascending Aorta CTSNet Content Mentioned 1.) Branch-First Arch Replacement: How to Do It 2.) Revisiting the Manougian Technique With Double-Patch 3.) Bentall Surgery via Right Anterior Minithoracotomy Other Items Mentioned 1.) EACTS/STS/AATS Guidelines on Temporary Mechanical Circulatory Support in Adult Cardiac Surgery 2.) The Cardiac Recovery Room 3.) Resident Video Competition 4.) 2025 CTSNet Recruitment Guide 5.) Career Center 6.) CTSNet Events Calendar Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.
Commentary by Dr. Jian'an Wang.
Interventional cardiologist and vascular specialist Dr. Scott Joransen breaks down vein disease - what it is, what causes it, and the warning signs and risk factors to look out for.Visit www.cardio.com for more information or to schedule an appointment with one of our providers.
In this episode, we review the high-yield topic of Interventional Studies from the Stats section.Follow Medbullets on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbullets
Join us for an interview with Dr. Grigorios Korosoglou, our 2025 Global PAD Interventional Angiologist of the Year, on the Heart of Innovation Radio Show!
Ever wondered what opportunities await through an academic career in pain management or interventional spine? Our RFC technology subcommittee member Michael Blatt, MD met with Zack McCormick, MD to learn more about his path towards a career involving founding and directing a fellowship program and a clinical research program, publishing hundreds of peer-reviewed articles, taking on leadership roles at his hospital and national organizations, and collaborating on medical device innovation. Episode Credits: Michael Blatt MD, Zack McCormick MD, Sanjana Ayyagari MD
"Female Leaders in Interventional Cancer Pain Management." From ASRA Pain Medicine News, August 2025. See the original article at www.asra.com/august25news for figures and references. This material is copyrighted. Support the show
This year is the 50th anniversary of the first transcatheter ASD closure in a human. To celebrate this achievement, this week we air a live interview from PICS 2025 in Chicago (conducted 8/26/25) with living interventional cardiology legend Dr. Terry King speaking about the events surrounding his landmark intervention as the first person to ever perform a transcatheter ASD closure with his partner, surgeon Dr. Noel Mills. In this one on one interview, Dr. King discusses how he came up with this idea with Dr. Mills and how he found a patient in which to proceed. He reviews what 'informed consent' was in 1975 and also how he and Dr. Mills accurately estimated ASD size in an era that preceded 2D echocardiography. Dr. King speaks about the role of family in his life and offers advice to the next generation. Finally, he shares with us what he is up to today and why he does not believe in retirement. Prepare to be excited and inspired by this wonderful figure in our field.
I. Paul Singh, MD; Constance Okeke, MD, MSCE; and Zarmeena Vendal, MD, convene to discuss the latest updates on drug delivery and procedural pharmaceuticals in glaucoma treatment—specifically regarding the intracameral bimatoprost implant (Durysta, AbbVie) and iDose TR (travoprost intracameral implant) 75 mcg (Glaukos). They each explain the role of these treatments in their practices and how to identify the noncompliant patients who are the best candidates for this intervention. They also review safety data behind these treatments and share pearls for getting started. Editorially independent content supported with advertising by Glaukos.
We continue our series on Applying to Residency with brand new SOM grad Shirin Parsa. She's a prelim surgery intern who will complete her residency in Integrated Interventional Radiology at the University of Maryland. She shares her residency application journey, including the mentorship she received, the interviews she went on, and how she crafted her rank list. Each of these conversations has pearls for all third—and fourth-year students, regardless of specialty. Listen in, and let us know what other specialties you'd like to learn about in this series.
Interventional cardiologist Dr. Jennifer Rodriguez breaks down the link between hypertension and stroke, sharing expert insights and prevention strategies. Visit www.cardio.com for more information or to schedule an appointment with one of our providers.Visit www.cardio.com for more information or to schedule an appointment with one of our providers.
This week on Clear Lake Connections Podcast presented by UTMB Health: Meet Dr. Arsalan Saleem InterventionalRadiologistIn this week's episode, we meet Dr. Arsalan Saleem, Associate Professor of Radiology at UTMB. Dr. Saleem explains what radiology is, how it is used and why it is so important to healthcare. He describes radiology as thebackbone of any medical system. All patients connect with radiology during their care. Ultrasounds, x-rays, MRI, CT scans are the most common procedures for imaging. Dr. Saleem discusses the remarkable technological advances in thelast decade for radiology. Scan times are faster, and the digital images are better which result in quicker diagnosis. Dr. Saleem also explains how radiology today can assist him with surgical procedures. Interventional radiology allowshim to perform procedures under image guidance to fix problems in the body without having to cut. Small puncture wounds can be used instead to speed up recovery times.
Professor Ziyad Hijazi of SIdra Medical joins Pediheart this week to celebrate Pediheart's 350th milestone and discuss his life and times from his early days in Jordan to the absolute heights of interventional cardiology. How did he meet Dr. Kurt Amplatz and become involved in the development of Amplatzer devices? Who were some of his mentors and what does he think about being a mentor? How did he come up with the idea for the PICS interventional course and how has he managed to do this consistently for over 20 years? What does he believe is important when thinking about a work/life balance? This is a rare opportunity to learn from someone who has seen and done it all in every corner of the world in pediatric cardiology. For those interested, this is the link to the PICS course in late August, 2025 in Chicago:https://www.picsymposium.com/home.html
This episode recorded live at the Becker's 22nd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference features Nikhil Shetty, COO of Midwest Interventional Spine Specialists. Dr. Shetty shares insights on the shift to outpatient care, staffing strategies, the expanding role of ASCs, and the promise of AI in streamlining clinical and administrative workflows.
Symptomatic gallstones that can't be treated with surgery? Interventional radiology can help. In this episode of BackTable, Dr. John Smirniotopoulos, IR at MedStar Health, joins Dr. Michael Barraza to share the latest advancements and techniques in biliary endoscopy. --- SYNPOSIS Dr. Smirniotopoulos reflects on his early work with cholangioscopy at Cornell, highlighting ongoing innovation and evolving tools. The conversation covers the practical aspects of patient selection, procedural steps, and overcoming technical challenges. Dr. Smirniotopoulos shares his personal experiences managing small and large biliary stones, emphasizing the important role of selecting appropriate equipment to navigate procedural challenges. Dr. Smirniotopoulos also highlights the collaborative role of surgeons and gastroenterologists throughout patient management. He also provides insights into the management of biliary strictures and emphasizes the importance of accurate billing and coding. The episode concludes with advice for clinicians seeking to integrate these techniques into their practice. --- TIMESTAMPS 00:00 - Introduction01:09 - Early Experiences with Biliary Endoscopy03:35 - Procedure Techniques and Tools05:36 - Patient Selection and Case Studies11:01 - Advanced Techniques and Equipment14:02 - Patient Management and Follow-Up18:21 - Technical Considerations and Best Practices20:14 - Managing Stones in the Gallbladder35:42 - Collaborating with Surgeons and GI Teams37:59 - Advice for New Practitioners
This episode recorded live at the Becker's 22nd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference features Nikhil Shetty, COO of Midwest Interventional Spine Specialists. Dr. Shetty shares insights on the shift to outpatient care, staffing strategies, the expanding role of ASCs, and the promise of AI in streamlining clinical and administrative workflows.
This episode recorded live at the Becker's 22nd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference features Nikhil Shetty, COO of Midwest Interventional Spine Specialists. Dr. Shetty shares insights on the shift to outpatient care, staffing strategies, the expanding role of ASCs, and the promise of AI in streamlining clinical and administrative workflows.
Interventional cardiology is rapidly evolving, with advances in imaging, devices, and techniques driving both innovation and rising expectations for safety and patient-centered outcomes. This week's editor's page highlights cutting-edge research and expert commentary on topics such as plaque vulnerability, stent performance, imaging-guided interventions, and long-term outcomes, reflecting both progress and ongoing challenges in the field. By bringing together this wealth of new science, the issue aims to inform clinical practice, encourage thoughtful decision-making, and inspire continued innovation in cardiovascular care.
Radiation segmentectomy: who, when, how? Interventional oncologists Dr. Nima Kokabi, Dr. Tyler Sandow, and Dr. Kavi Krishnasamy continue their in-studio discussion on all things Y90 in Part 4 of Dosimetry University, focusing on specific applications of radiation segmentectomy. --- This podcast is supported by: Sirtexhttps://www.sirtex.com/ Medtronic Emprinthttps://www.medtronic.com/emprint --- SYNPOSIS This session kicks off with a discussion on the curative potential of Y90, comparing it to other curative modalities like resection. The doctors discuss the importance of achieving a complete pathological necrosis (CPN) with Y90 for better survival outcomes, especially in the context of liver transplantation. The conversation also covers personalized approaches for treating liver-dominant metastatic cancers using Y90, and strategic considerations when choosing between techniques like radiation lobectomy, thermal ablation, and chemoembolization. The interventional oncologists explore the viability of radiation segmentectomy in treating small lesions and discuss data supporting its efficacy. Real-world clinical cases are examined to highlight the practical application of these therapies, their impact on overall survival, and the intricacies of dosimetry and patient selection. --- TIMESTAMPS 00:00 - Introduction01:07 - Ablative Y90 Curative Outcomes and Survival Rates02:16 - Radiation Segmentectomy vs. Ablation09:22 - Case Study: Metastatic Colorectal Cancer18:06 - Tumor Distinction on Cone Beam CT19:58 - Case Study: 77-Year-Old Female with Breast and Colorectal Cancer21:09 - Challenges and Techniques in Selective Radiation Segmentectomy24:28 - Avastin and Y9028:16 - Case Study: 53-Year-Old Male with Metastatic Colorectal Cancer29:40 - Radiation Lobectomy and Hypertrophy Strategies32:37 - Approaches for Metastatic and HCC Patients
This Oncology PER®Spectives™ podcast examines the recent advancements in the treatment landscape for advanced melanoma.In this activity, expertsYana Najjar, MD; Rahul A. Sheth, MD, FSIR; and Douglas Johnson, MD, MSCI, discuss the challenges of immune checkpoint inhibitor resistance and the practical strategies for overcoming this by using direct intratumoral injections of oncolytic viral immunotherapies, which rely on close interdisciplinary collaboration between medical oncologists and interventional radiologists.
Welcome to Season 2 of the Orthobullets Podcast.Today's show is Podiums, where we feature expert speakers from live medical events. Today's episode will feature Dr. Farhan Siddiqi and is titled "Interventional Spine: Which Procedures are Appropriate? Boundary of Spine Surgeon and Interventional Physician"Follow Orthobullets on Social Media:FacebookInstagram LinkedIn
In this episode of Critical Care Time, Dr. Joshua Boster joins Cyrus and Nick to explore how interventional pulmonary (IP) skills can be life-saving in the ICU. From managing malignant central airway obstruction with rigid bronchoscopy to navigating pleural disease, persistent air leaks, and even life-threatening hemoptysis, Dr. Boster shares practical insights from the front lines. Listeners will learn how IP tools can transform critical care decision-making and offer meaningful interventions when time and options are limited. Whether you're an intensivist, a trainee, or just IP-curious, this episode highlights procedures that not only restore patency—but restore hope. Give it a listen, leave us a review and let us know what you think! Hosted on Acast. See acast.com/privacy for more information.
In this edition of The Rob & Jai Show, the OIS Podcast welcomes Adam Szaronos, CEO of IanTrek, for a wide-ranging conversation on innovation, leadership, and unlocking new pathways in glaucoma care. Adam walks us through his career journey from Alcon to TearLab to leading IanTrek, where he's now championing a new class of glaucoma procedures with AloeFlow™—a minimally invasive, tissue-based implant that activates the uveoscleral pathway.Together with hosts Dr. Rob Rothman and Dr. Jai Parekh, Adam discusses:The evolution of his career from medical device sales to surgical commercialization and C-suite leadership.Why the uveoscleral pathway, long leveraged in pharmacology, has remained unaddressed in surgical glaucoma—and how IanTrek is changing that.The material science breakthrough that differentiates AloeFlow™ from past uveoscleral attempts like CyPass.The market opportunity for post-MiGs patients and how IanTrek's platform opens new treatment options without burning surgical real estate.Insights into IanTrek's growing bio-interventional pipeline and what's ahead in 2025 and beyond.Whether you're a glaucoma surgeon, an investor, or a medtech strategist, this episode is a must-listen on where glaucoma innovation is headed. Subscribe to the OIS Podcast today and stay connected to the future of ophthalmology.
Interventional physiatrist Francisco M. Torres discusses his article "The key to longevity: fitness, mindset, and nutrition." He challenges societal assumptions about inevitable decline after age sixty, arguing that joy, vitality, and strength can thrive with the right approach. Francisco emphasizes a combination of factors: tailored fitness routines incorporating strength, cardiovascular, and flexibility exercises; listening to the body and finding personal joy in movement; and prioritizing nourishing foods like fruits, vegetables, whole grains, and lean proteins. Crucially, he highlights the power of mindset, citing research showing that "subjective age" and satisfaction with aging correlate more strongly with well-being and "flourishing" than chronological age does. Francisco stresses that viewing aging as enabling wisdom and experience, rather than limiting, combined with community connection through shared activities, is key to embracing health and vitality at any stage of life. Our presenting sponsor is Microsoft Dragon Copilot. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Now you can streamline and customize documentation, surface information right at the point of care, and automate tasks with just a click. Part of Microsoft Cloud for Healthcare, Dragon Copilot offers an extensible AI workspace and a single, integrated platform to help unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise—and it's built on a foundation of trust. It's time to ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended
In today's episode of the Legal Nurse Podcast, we delve into the life-saving world of cardiac stents with expert cardiologist Joshua Willis. Discover the evolution of stents, from their inception to their transformative role in treating heart disease. Joshua shares insights into the critical procedures that follow stent insertion and navigates the complexities of balancing patient care with available resources. You'll discover how these medical advancements have changed lives and the collaborative decision-making involved in this vital field. Tune in and explore the fascinating journey of cardiac care! Heart Procedures: Cardiac Stents and Beyond Addresses these Questions: Join us for this episode, during which we discuss these questions. How did the concept of cardiac stents develop, and who was a key figure in their development? What are the differences between bare metal stents and drug-eluting stents, and how do they function in preventing coronary artery blockages? What are the typical medications used post-stent insertion to prevent clot formation, and why are they crucial? How does the radial approach differ from the femoral approach in cardiac procedures, and why has it become more favored? What role does shared governance play in deciding between stent insertion and coronary artery bypass surgery for a patient? Listen to our podcasts or watch them using our app, Expert.edu, available at legalnursebusiness.com/expertedu. Get the free transcripts and also learn about other ways to subscribe. Go to Legal Nurse Podcasts subscribe options by using this short link: http://LNC.tips/subscribepodcast. Are you finding it tough to Grow Your LNC Business? You are not alone! Join us for the 12th LNC SUCCESS® 3-DAY ONLINE CONFERENCE on November 13, 14, & 15, 2025! It's a chance to learn how to overcome common challenges and gain the skills you need to succeed in legal nurse consulting. Connect with industry experts who will share practical strategies for standing out, building strong relationships with attorneys, and effectively presenting your value. No matter your experience level, this conference will empower you to discover fresh opportunities and advance your business. What to Expect Expert-Led Sessions: Engage with sessions led by top industry professionals. Interactive Workshops: Participate in hands-on workshops designed to enhance your consulting skills. Networking Opportunities: Build lasting connections with peers and potential clients. Resource Materials: Receive exclusive materials that will support your ongoing professional development. Don't miss this chance to make a real impact on your business. Register Today Secure your spot at the 12th LNC SUCCESS® 3-DAY ONLINE CONFERENCE on November 13, 14, & 15, 2025, and take your first step toward becoming a leading legal nurse consultant! We look forward to welcoming you to this pivotal event in February 2025! Your Presenter for Heart Procedures: Cardiac Stents and Beyond Joshua M Willis, MD Dr. Willis completed a cardiology fellowship at the Cleveland Clinic Foundation (2007-2010) and an Interventional Cardiology fellowship at the University of Florida (2010-2011). In 2011, he took a private cardiology practice job in Chattanooga, Tennessee, splitting his time between hospital-based procedures (cardiac catheterizations, percutaneous coronary interventions, Swan Ganz catheterization for invasive hemodynamic measurements, Impella device placement etc.) and clinic duties, and seeing approximately 24-26 patients per full clinic day. His job responsibilities at Wellstar include three days in the hospital, providing Interventional and General Cardiology coverage and 1.5 days in clinic seeing outpatients, total of 35-40 outpatient visits per week. Connect with Joshua M Willis, MD by email at cardioexpertwitness@gmail.com,
What are the 10 Commandments of Being a Female Interventional Radiologist? Guest Dr. Maureen Kohi (Chair of Radiology at University of North Carolina Chapel Hill) sits down with host Dr. Ally Baheti to discuss the details of her popular lecture topic and how these 10 rules are actually applicable to all current and future interventional radiologists. --- SYNPOSIS Dr. Kohi begins by going through each of the 10 points - offering detailed advice throughout, while also acknowledging nuances and challenges women and men can encounter in medicine and best approaches. Dr. Kohi also speaks on how to build and navigate strong relationships with industry. The episode concludes with several more pearls of wisdom as Dr. Kohi shares the last of the 10 commandments. --- TIMESTAMPS 00:00 - Introduction 01:08 - 10 Commandments of Being a Female IR 23:06 - Importance of Involvement in Professional Societies 24:46 - Childcare Concerns in Professional Settings 28:58 - Making the Leadership Leap 35:24 - Navigating Gender Bias in Professional Environments 41:51 - Prioritizing Health, Family, and Personal Fulfillment --- RESOURCES From Good to Great (Book): https://a.co/d/gXWW1Qp Start With Why (Book): https://a.co/d/hgaadIt
Join Executive Producer and Host Shravani Durbhakula, MD, MPH, MBA, and Co-Host Mustafa Broachwala, DO, for a pivotal episode of the Pain Matters Podcast where we address the recent BMJ publication, “Common interventional procedures for chronic non-cancer spine pain: a systematic review and network meta-analysis of randomized trials,” and the associated guideline. Steven Cohen, MD, Feinberg School of Medicine Northwestern University, Lynn R. Kohan, MD, University of VA Medical School, Zachary McCormick, MD, University of Utah, Nathaniel M. Schuster, MD, University of California, San Diego, Daniel Larach, MD, MS, MA, Vanderbilt University, Hance Clarke, MD, FRCPC, PhD, University of Toronto and President of the Canadian Pain Society, Hemant Kalia, MD, MPH, FIPP, Invision Health, and present diverse perspectives on the publication's claims and the systematic review and meta-analysis methods behind it.In this episode, you'll learn:The podcast underlines the necessity for comprehensive, unbiased systematic reviews and meta-analyses to inform clinical guidelines effectively.Experts caution against the misinterpretation of studies and the potential consequences for policy and access to interventional pain procedures.Advocates call for unified efforts in the pain medicine community to pursue legislative and regulatory reforms that align with current evidence and patient needs.The conversation underscores the pivotal role of personalized patient care and clinically validated techniques in improving outcomes and preserving practice legitimacy.The podcast highlights the risk of reducing access to viable interventional pain treatments if skewed interpretations of data shape healthcare policies.Tune in to discover how these leading experts address the controversies, advocate for robust clinical evidence, and highlight the urgent need for unified advocacy in shaping practical, patient-centered guidelines.Be sure to subscribe so you don't miss our next episode.Reference: Wang X, Martin G, Sadeghirad B, Chang Y, Florez I D, Couban R J et al. Common interventional procedures for chronic non-cancer spine pain: a systematic review and network meta-analysis of randomised trials BMJ 2025; 388 :e079971 doi:10.1136/bmj-2024-079971
Drs. Davinder Grover and Ronald Fellman join host Dr. Andrew Pouw to discuss their latest innovative surgical advancement: interventional valve-enhancing trabeculotomy (iVEnT), an angle-based minimally invasive glaucoma surgery (MIGS) procedure. Compared with a traditional goniotomy, this alternative approach may be less invasive, sparing tissue and offering faster visual recovery for glaucoma patients. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
Episode 68 - Unpacking TNM9 for the Interventional Pulmonologist by AABIP
Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Dr. Sean Ianchulev, CEO of Iantrek, is developing a new approach to treating glaucoma, which involves a biologic implant that can be customized to the patient's disease progression. This technology is designed to be more durable compared to traditional glaucoma treatments, which often require lifelong use of eye drops. This treatment is a combination of microinterventional technology with biologic tissue technology to transform the approach to eye care. Sean explains, "So we are a first not only for ophthalmology but also for medicine. We are the first, made of biologic technology, and we're to implant that tissue without any hardware, which is important because it minimizes implantable response. We can treat glaucoma patients who need intraocular pressure opening by opening and stenting the outflow pathway in a very unprecedented way. So, we've created a new categorical treatment, which we call bio-interventional." "I think in cataract, we can say we've probably been able to cure that disease by cataract surgery and have a permanent cure. Unfortunately, glaucoma is difficult, affecting the optic nerve. And when you talk about neurodegenerative diseases, we're not yet there where we can cure them, but if we can slow them down, and we can slow them down to the point where it does not impact somebody's well-being and vision until the end of their lifespan, I think that's almost equivalent to cure because we've been able to enable them to have a productive life." #Iantek #Glaucoma #Innovation #Biointerventional #Microinterventional #Biotissue #EyeCare #Ophthalmology iantrekmed.com Download the transcript here
Dr. Sean Ianchulev, CEO of Iantrek, is developing a new approach to treating glaucoma, which involves a biologic implant that can be customized to the patient's disease progression. This technology is designed to be more durable compared to traditional glaucoma treatments, which often require lifelong use of eye drops. This treatment is a combination of microinterventional technology with biologic tissue technology to transform the approach to eye care. Sean explains, "So we are a first not only for ophthalmology but also for medicine. We are the first, made of biologic technology, and we're to implant that tissue without any hardware, which is important because it minimizes implantable response. We can treat glaucoma patients who need intraocular pressure opening by opening and stenting the outflow pathway in a very unprecedented way. So, we've created a new categorical treatment, which we call bio-interventional." "I think in cataract, we can say we've probably been able to cure that disease by cataract surgery and have a permanent cure. Unfortunately, glaucoma is difficult, affecting the optic nerve. And when you talk about neurodegenerative diseases, we're not yet there where we can cure them, but if we can slow them down, and we can slow them down to the point where it does not impact somebody's well-being and vision until the end of their lifespan, I think that's almost equivalent to cure because we've been able to enable them to have a productive life." #Iantek #Glaucoma #Innovation #Biointerventional #Microinterventional #Biotissue #EyeCare #Ophthalmology iantrekmed.com Listen to the podcast here
Interventional radiology is unique in the way that much of what an IR's practice looks like is extremely contingent upon their practice setting following training - whether it be community, academic, private, or hybrid. Dr. Mark Wilson joins host Dr. Donald Garbett to discuss his own journey of transitioning from a large, physician owned group to forming his own private IR practice in Spokane, Washington following a major hospital contract shift. --- This podcast is supported by: Medtronic IN.PACT 018 DCB https://www.medtronic.com/018 --- SYNPOSIS Dr. Wilson shares the emotional impact of the career shift, and the technical aspects of how he was able to succeed following the change, and the details that went into creating his own private IR-only group and securing contracts with local hospitals. The doctors also spend time on the financial dynamics between DR and IR, as well as the true dollar value and impact IR brings to hospitals. The episode concludes with Dr. Wilson's practical and thorough guide on how one can go about starting up their own IR-only private practice. --- TIMESTAMPS 00:00 - Introduction 03:02 - Forming a New IR Group 04:43 - Impact of Practice Changes 11:02 - IR's Value to Hospitals 30:49 - Independent IR Practice Set-Up 36:38 - Conclusion --- RESOURCES Karage, 2024. Attrition Rates in Interventional Radiology Integrated Residency Programs: https://pubmed.ncbi.nlm.nih.gov/39586539/
It might be time to rethink your liver biopsy technique. Transfemoral transcaval core-needle liver biopsy has demonstrated key advantages over the transjugular approach and has become increasingly popular in recent years. Interventional radiologists Dr. Jacob Cynamon and Dr. Kapil Wattamwar join host Dr. Sabeen Dhand to discuss the inception and advantages of their novel approach. --- This podcast is supported by: Reflow Medical https://www.reflowmedical.com/ --- SYNPOSIS The doctors start with how they began using the transfemoral transcaval approach, along with the literature they published following adoption of this novel technique shortly thereafter. Dr. Cynamon and Dr. Wattamwar then go on to discuss the technique in detail, providing a thorough step-by-step and pausing to mention key considerations. The episode concludes with the doctors emphasizing the safety and efficacy of the transfemoral transcaval approach, citing specific findings and sharing exemplary cases. --- TIMESTAMPS 00:00 - Introduction 05:47 - Percutaneous vs. Transvenous Biopsies 08:56 - Evolution of Transfemoral Biopsies 12:41 - Comparing Transjugular and Transfemoral Approaches 24:52 - Pre-Procedural Imaging and Sheath Selection 29:23 - Complications and Case Studies 35:46 - Transcaval Biopsy Technique 45:00 - Conclusion --- RESOURCES Cynamon, 2016. Transfemoral Transcaval Core-Needle Liver Biopsy: An Alternative to Transjugular Liver Biopsy: https://pubmed.ncbi.nlm.nih.gov/26723528/ Wattamar, 2020. Transjugular versus Transfemoral Transcaval Liver Biopsy: A Single-Center Experience in 500 Cases: https://pubmed.ncbi.nlm.nih.gov/32798119/ Wattamar, 2022. The Use of the Transfemoral Transcaval Liver Biopsy Technique for Biopsies of Hepatic Masses: https://pubmed.ncbi.nlm.nih.gov/36182256/ Wattamar, 2022. Transcaval Creation of a Portal Vein Target for Transjugular Intrahepatic Portosystemic Shunt in a Patient with Portal Vein Thrombosis: https://pubmed.ncbi.nlm.nih.gov/34448032/
Dr. Kien Vuu, widely celebrated as 'Doctor V,' is a beacon of resilience and human potential. His journey from an infant boat refugee to a renowned medical expert and speaker is a story of remarkable triumph. With tenure at UCLA and the National Institutes of Health as an Interventional and Diagnostic Radiologist, Doctor V has expanded his expertise to include longevity medicine, human potential, and spirituality. He is the founder of VuuMD Performance and Longevity, advising a diverse clientele including top athletes and Fortune 500 companies. As the bestselling author of 'Thrive State,' his compelling keynotes and workshops have inspired audiences at organizations like Whole Foods and Bank of America, and on platforms such as NBC and Netflix. Doctor V's unique blend of medical acumen and engaging storytelling ignites audiences, empowering them to unlock their full potential and achieve optimal health and performance in both personal and professional spheres.Links to promote:thrivestatestarter.commythrivestate.com/toolkit LIQUID COLLAGENhttps://modere.io/TB2OkThttps://modere.io/BZDgOABALANCED, BEAUTIFUL, ABUNDANT Retreathttps://wellnessmarketingltd.com/balanced-beautiful-abundant-retreat/FREE BREAKTHROUGH CALLhttps://calendly.com/rebeccaelizabethwhitman/breakthroughFor more information go to…https://www.rebeccaelizabethwhitman.com/https://linktr.ee/rebeccaewhitman
© 2020-2026 Ivy Podcast Discovery LLC
